Chinese General Practice ›› 2023, Vol. 26 ›› Issue (33): 4187-4193.DOI: 10.12114/j.issn.1007-9572.2023.0115
• Original Research • Previous Articles Next Articles
Received:
2023-02-01
Revised:
2023-05-28
Published:
2023-11-20
Online:
2023-06-13
Contact:
FENG Xiaodong
通讯作者:
冯晓东
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0115
评分 | 表现 |
---|---|
0分 | 无缺损症状;无神经损伤 |
1分 | 提尾时对侧前肢内收屈曲;轻度神经损伤 |
2分 | 向对侧追尾式旋转;中度神经损伤 |
3分 | 行走费力且向对侧倾倒;重度神经损伤 |
4分 | 不能自发活动伴意识丧失;极重度神经损伤 |
Table 1 Zea-Longa scoring criteria
评分 | 表现 |
---|---|
0分 | 无缺损症状;无神经损伤 |
1分 | 提尾时对侧前肢内收屈曲;轻度神经损伤 |
2分 | 向对侧追尾式旋转;中度神经损伤 |
3分 | 行走费力且向对侧倾倒;重度神经损伤 |
4分 | 不能自发活动伴意识丧失;极重度神经损伤 |
基因 | 引物序列(5'→3') |
---|---|
BDNF | F:GACTCCCCGGCTTGGAGAAG R:CTGAGGGAACCCGGTCTCAT |
TrkB | F:GGATTCTGCCTGCTGGTGAT R:ACCCATCCAGGGGGATCTTAT |
PI3K | F:ATCGACCTACACTTGGGGGA R:CAATATCTTCTGGCCGGGCT |
Akt | F:AGGAGGTCATCGTTGCCAAG R:GGTCGTGGGTCTGGAATGAG |
GAPDH | F:ACAGCAACAGGGTGGTGGAC R:TTTGAGGGTGCAGCGAACTT |
Table 2 RT-PCR primer sequence
基因 | 引物序列(5'→3') |
---|---|
BDNF | F:GACTCCCCGGCTTGGAGAAG R:CTGAGGGAACCCGGTCTCAT |
TrkB | F:GGATTCTGCCTGCTGGTGAT R:ACCCATCCAGGGGGATCTTAT |
PI3K | F:ATCGACCTACACTTGGGGGA R:CAATATCTTCTGGCCGGGCT |
Akt | F:AGGAGGTCATCGTTGCCAAG R:GGTCGTGGGTCTGGAATGAG |
GAPDH | F:ACAGCAACAGGGTGGTGGAC R:TTTGAGGGTGCAGCGAACTT |
组别 | 只数 | 术后2 h | 治疗第7天 | 治疗第14天 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0分 | 1分 | 2分 | 3分 | 4分 | 0分 | 1分 | 2分 | 3分 | 4分 | 0分 | 1分 | 2分 | 3分 | 4分 | ||
空白组 | 12 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 |
假手术组 | 12 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 |
模型组abcdef | 12 | 0 | 1(8.3) | 2(16.7) | 9(75.0) | 0 | 0 | 2(16.7) | 3(25.0) | 7(58.3) | 0 | 0 | 3(25.0) | 7(58.3) | 2(16.7) | 0 |
电针组abgh | 12 | 0 | 1(8.3) | 3(25.0) | 8(66.7) | 0 | 0 | 6(50.0) | 4(33.3) | 2(16.7) | 0 | 4(33.3) | 7(58.3) | 1(8.3) | 0 | 0 |
H值 | 42.53 | 42.17 | 37.81 | |||||||||||||
P值 | <0.05 | <0.05 | <0.05 |
Table 3 Comparison of Zea-Longa scores among 4 groups of rats
组别 | 只数 | 术后2 h | 治疗第7天 | 治疗第14天 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0分 | 1分 | 2分 | 3分 | 4分 | 0分 | 1分 | 2分 | 3分 | 4分 | 0分 | 1分 | 2分 | 3分 | 4分 | ||
空白组 | 12 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 |
假手术组 | 12 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 | 12(100.0) | 0 | 0 | 0 | 0 |
模型组abcdef | 12 | 0 | 1(8.3) | 2(16.7) | 9(75.0) | 0 | 0 | 2(16.7) | 3(25.0) | 7(58.3) | 0 | 0 | 3(25.0) | 7(58.3) | 2(16.7) | 0 |
电针组abgh | 12 | 0 | 1(8.3) | 3(25.0) | 8(66.7) | 0 | 0 | 6(50.0) | 4(33.3) | 2(16.7) | 0 | 4(33.3) | 7(58.3) | 1(8.3) | 0 | 0 |
H值 | 42.53 | 42.17 | 37.81 | |||||||||||||
P值 | <0.05 | <0.05 | <0.05 |
组别 | 只数 | 第9天 | 第10天 | 第11天 | 第12天 | 第13天 |
---|---|---|---|---|---|---|
空白组 | 12 | 38.6±5.0 | 31.1±5.9 | 25.8±4.5 | 13.9±3.7 | 8.4±3.3 |
假手术组 | 12 | 37.7±7.2 | 31.4±6.2 | 25.1±5.6 | 14.0±4.2 | 8.2±3.4 |
模型组 | 12 | 51.9±6.3ab | 42.4±6.0ab | 34.5±5.0ab | 27.5±5.1ab | 20.7±5.9ab |
电针组 | 12 | 46.5±6.2c | 37.6±5.1c | 29.5±4.9c | 20.4±3.3c | 12.4±4.2c |
F值 | F交互=1.191,F组间=52.513,F时间=277.985 | |||||
P值 | P交互=0.30,P组间<0.05,P时间<0.05 |
Table 4 Comparison of incubation period among 4 groups of rats
组别 | 只数 | 第9天 | 第10天 | 第11天 | 第12天 | 第13天 |
---|---|---|---|---|---|---|
空白组 | 12 | 38.6±5.0 | 31.1±5.9 | 25.8±4.5 | 13.9±3.7 | 8.4±3.3 |
假手术组 | 12 | 37.7±7.2 | 31.4±6.2 | 25.1±5.6 | 14.0±4.2 | 8.2±3.4 |
模型组 | 12 | 51.9±6.3ab | 42.4±6.0ab | 34.5±5.0ab | 27.5±5.1ab | 20.7±5.9ab |
电针组 | 12 | 46.5±6.2c | 37.6±5.1c | 29.5±4.9c | 20.4±3.3c | 12.4±4.2c |
F值 | F交互=1.191,F组间=52.513,F时间=277.985 | |||||
P值 | P交互=0.30,P组间<0.05,P时间<0.05 |
组别 | 只数 | 穿越平台次数 |
---|---|---|
空白组 | 12 | 7.99±2.71 |
假手术组 | 12 | 7.64±3.20 |
模型组 | 12 | 2.19±1.52ab |
电针组 | 12 | 4.87±1.65c |
F值 | 15.57 | |
P值 | <0.05 |
Table 5 Comparison of times of crossing the effective region of the platform among 4 groups of rats
组别 | 只数 | 穿越平台次数 |
---|---|---|
空白组 | 12 | 7.99±2.71 |
假手术组 | 12 | 7.64±3.20 |
模型组 | 12 | 2.19±1.52ab |
电针组 | 12 | 4.87±1.65c |
F值 | 15.57 | |
P值 | <0.05 |
组别 | 例数 | BDNF | TrkB | PI3K | Akt |
---|---|---|---|---|---|
空白组 | 3 | 1.00±0.09 | 1.00±0.02 | 1.00±0.12 | 1.00±0.20 |
假手术组 | 3 | 0.99±0.04 | 1.00±0.02 | 1.03±0.10 | 1.00±0.10 |
模型组 | 3 | 0.23±0.03ab | 0.48±0.10ab | 0.55±0.04ab | 0.53±0.05ab |
电针组 | 3 | 0.76±0.08c | 0.75±0.07c | 0.88±0.16c | 0.90±0.09c |
F值 | 91.95 | 44.87 | 11.45 | 10.35 | |
P值 | <0.05 | <0.05 | <0.05 | <0.05 |
Table 6 Comparison of mRNA levels of BDNF,TrkB,PI3K and Akt in hippocampal tissues of four groups
组别 | 例数 | BDNF | TrkB | PI3K | Akt |
---|---|---|---|---|---|
空白组 | 3 | 1.00±0.09 | 1.00±0.02 | 1.00±0.12 | 1.00±0.20 |
假手术组 | 3 | 0.99±0.04 | 1.00±0.02 | 1.03±0.10 | 1.00±0.10 |
模型组 | 3 | 0.23±0.03ab | 0.48±0.10ab | 0.55±0.04ab | 0.53±0.05ab |
电针组 | 3 | 0.76±0.08c | 0.75±0.07c | 0.88±0.16c | 0.90±0.09c |
F值 | 91.95 | 44.87 | 11.45 | 10.35 | |
P值 | <0.05 | <0.05 | <0.05 | <0.05 |
组别 | 只数 | BDNF | TrkB | p-PI3K/PI3K | p-Akt/Akt |
---|---|---|---|---|---|
空白组 | 3 | 0.32±0.07 | 0.95±0.04 | 0.58±0.01 | 0.33±0.03 |
假手术组 | 3 | 0.32±0.07 | 0.91±0.06 | 0.59±0.04 | 0.35±0.03 |
模型组 | 3 | 0.08±0.03ab | 0.43±0.02ab | 0.31±0.10ab | 0.17±0.02ab |
电针组 | 3 | 0.23±0.07c | 0.65±0.06c | 0.54±0.09c | 0.32±0.09c |
F值 | 10.58 | 45.22 | 10.66 | 7.62 | |
P值 | <0.05 | <0.05 | <0.05 | <0.05 |
Table 7 Comparison of protein relative expression levels of BDNF,TrkB,p-PI3K/PI3K and p-Akt/Akt in hippocampal tissues of four groups
组别 | 只数 | BDNF | TrkB | p-PI3K/PI3K | p-Akt/Akt |
---|---|---|---|---|---|
空白组 | 3 | 0.32±0.07 | 0.95±0.04 | 0.58±0.01 | 0.33±0.03 |
假手术组 | 3 | 0.32±0.07 | 0.91±0.06 | 0.59±0.04 | 0.35±0.03 |
模型组 | 3 | 0.08±0.03ab | 0.43±0.02ab | 0.31±0.10ab | 0.17±0.02ab |
电针组 | 3 | 0.23±0.07c | 0.65±0.06c | 0.54±0.09c | 0.32±0.09c |
F值 | 10.58 | 45.22 | 10.66 | 7.62 | |
P值 | <0.05 | <0.05 | <0.05 | <0.05 |
[1] |
GBD Causes of Death Collaborators. Global,regional,and national age-sex specific mortality for 264 causes of death,1980-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet,2017,390(10100):1151-1210. DOI:10.1016/S0140-6736(17)32152-9.
|
[2] |
|
[3] |
中国卒中学会,卒中后认知障碍管理专家委员会. 卒中后认知障碍管理专家共识[J]. 中国卒中杂志,2017,12(6):519-531. DOI:10.3969/j.issn.1673-5765.2017.06.011.
|
[4] |
高静,白艳杰,冯晓东. 《欧洲卒中组织与欧洲神经病学学会卒中后认知障碍的联合指南》解读[J]. 华西医学,2022,37(5):641-645. DOI:10.7507/1002-0179.202204020.
|
[5] |
苏凯奇,高静,李洁莹,等. 基于古今医案云平台分析针刺治疗中风后认知障碍选穴规律[J]. 中国针灸,2022,42(1):99-103. DOI:10.13703/j.0255-2930.20201123-k0001.
|
[6] |
刘娇,冯晓东. 电针百会、神庭穴配合康复训练治疗脑卒中后认知障碍临床研究[J]. 中医学报,2013,28(4):608-610.
|
[7] |
薛洋,孙伟娟,刘飞来,等. 电针神庭、百会联合功能康复训练治疗脑卒中后认知障碍42例[J]. 中医研究,2018,31(1):57-60. DOI:10.3969/j.issn.1001-6910.2018.01.25.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
黎帅,谭洁,张泓,等. 穴位埋线对慢性缺血性认知障碍模型大鼠空间学习记忆能力及海马兴奋性氨基酸毒性相关蛋白的影响[J]. 针刺研究,2018,43(6):347-352. DOI:10.13702/j.1000-0607.170385.
|
[14] |
李忠仁. 实验针灸学[M]. 2版. 北京:中国中医药出版社,2007.
|
[15] |
詹杰,潘锐焕,郭友华,等. 针刺百会、神庭联合基础治疗和常规康复训练治疗脑卒中后认知障碍:随机对照研究[J]. 中国针灸,2016,36(8):803-806. DOI:10.13703/j.0255-2930.2016.08.007.html.
|
[16] |
|
[17] |
|
[18] |
|
[19] |
高静,赖名殷,梅氏清心,等. 电针对抑郁大鼠前额叶脑源性神经营养因子/哺乳动物雷帕霉素复合物1通路及突触可塑性的影响[J]. 针刺研究,2022,47(1):15-20,32. DOI:10.13702/j.1000-0607.201293.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[1] | BAI Haiwei, MI Xiaokun, LIU Qingrui, ZHU Lin, WANG Yingnan, LIU Junyan, HAN Ying. Predictive Value of Serum Uric Acid in Perioperative Acute Ischemic Stroke in Patients with Non-small Cell Lung Cancer [J]. Chinese General Practice, 2023, 26(36): 4545-4551. |
[2] | LUO Weigang, YIN Yuanyuan, LIU Wanhu, XU Yuzhu, CAO Xiaoyun, BU Wei, ZHANG Lingyan, REN Huiling. Correlation of Triglyceride Glucose Index with Early Neurological Deterioration in Patients with Single Subcortical Infarction [J]. Chinese General Practice, 2023, 26(35): 4419-4424. |
[3] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[4] | YIN Miaomiao, CUI Liling, LI Yaqing, WANG Liqun, ZHANG Yue, WU Jialing. Effect of Dual Task on Walking Ability in Posterior Circulation Ischemic Stroke Patients with Vestibular Symptoms [J]. Chinese General Practice, 2023, 26(33): 4207-4212. |
[5] | JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079. |
[6] | YANG Yuxuan, ZHANG Han, DU Juan, WANG Lingling, XIE Yulei, YIN Kaiming, ZHANG Bo. Value of an Dynamic Eye-tracking Task in Assessing Unilateral Spatial Neglect after Stroke [J]. Chinese General Practice, 2023, 26(32): 4020-4025. |
[7] | ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832. |
[8] | XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840. |
[9] | LIU Yue, LIU Qi, DONG Hui, LIU Yaling. Neuropsychological Changes of Cognitive Reverters after Stroke Based on the Montreal Cognitive Assessment (MoCA) with a Double Threshold [J]. Chinese General Practice, 2023, 26(27): 3417-3422. |
[10] | ZHENG Siting, HE Chunyu, ZHOU Jun, KONG Ye, YANG Xinyao, ZHOU Haiying, WEI Xiaofei. Summary of Best Evidence for Self-Management of Patients with Motor Dysfunction after Stroke [J]. Chinese General Practice, 2023, 26(26): 3230-3237. |
[11] | Expert group of expert consensus on the application of ulinastatin in common clinical critical illness. Expert Consensus on the Application of Ulinastatin in Common Clinical Critical Illness [J]. Chinese General Practice, 2023, 26(26): 3207-3219. |
[12] | WANG Xiaowen, XIAO Tongling, WANG Yi, YANG Ying, XIA Xiaoshuang, LI Xin. Relationship between Homocysteine Level and Acute Kidney Injury in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(26): 3290-3296. |
[13] | DU Yuying, WANG Cailing, CUI Senlin, LEI lei, WANG Yanping, SONG Xueqin, HAN Shuqin, ZHANG Yanmei, WANG Baolan, HUANG Haixia, CHEN Mi, YAN Huirong, LI Dong, ZHANG Jingjing, REN Yu. Analysis of Appropriate Technology Promotion for Stroke Rehabilitation in Southern Xinjiang [J]. Chinese General Practice, 2023, 26(25): 3178-3184. |
[14] | ZHANG Guoqing, TONG Tingting, WANG Ying, LI Kuiwu, ZHANG Lida, WU Xiaoqing, LI Chenglong, WANG Junli, ZHANG Junyu, HAN Wei. Effect and Mechanism of Tongdu Tiaoshen Electroacupuncture Pretreatment-mediated MiR-124-3p/GSK-3β/Cyp-D Signaling Pathway on Mitochondrial Permeability Transition Pore in Cerebral Cortex of Rats with Cerebral Ischemia-reperfusion Injury [J]. Chinese General Practice, 2023, 26(24): 3050-3060. |
[15] | SHEN Huiwen, LIN Yongzhong, CHEN Shuliang, ZHANG Lihong, MA Chunye, MA Deyuan, ZHANG Ce. Precise Thrombolytic Treatment for Stroke Using AI-based Algorithms: a Real-world Study [J]. Chinese General Practice, 2023, 26(17): 2070-2077. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||